Edition:
India

Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)

2607.HK on Hong Kong Stock

22.70HKD
23 May 2018
Change (% chg)

HK$-0.30 (-1.30%)
Prev Close
HK$23.00
Open
HK$23.00
Day's High
HK$23.85
Day's Low
HK$22.70
Volume
7,195,800
Avg. Vol
7,225,645
52-wk High
HK$24.25
52-wk Low
HK$18.20

Latest Key Developments (Source: Significant Developments)

Shanghai Pharma To Acquire An Indirect Stake In Guangzhou's Techpool Bio-Pharma
Monday, 21 May 2018 

May 21 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::SAYS ITS HONG KONG UNIT PLANS TO ACQUIRE TAKEDA CHROMO BETEILIGUNGS AG TO INDIRECTLY OWN 26.34 PERCENT OF TECHPOOL BIO-PHARMA CO., LTD.SAYS TRANSACTION PRICE AT $144 MILLION.SAYS ITS DIRECT AND INDIRECT STAKES IN TECHPOOL BIO-PHARMA TO TOTAL AROUND 67.14 PERCENT AFTER THE DEAL.  Full Article

Shanghai Pharmaceuticals Holding and unit receive approval for drug clinical trial
Friday, 18 May 2018 

May 18(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says co and unit received approval for drug clinical trial for a kind of tablet SPH3348, from China Food and Drug Administration.Says the tablet is mainly used for tumour treatment .  Full Article

Shanghai Pharmaceuticals Holding to pay cash dividend of 3.8 yuan (pre-tax) for every 10 shares
Monday, 26 Mar 2018 

March 26 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says it plans to pay a cash dividend of 3.8 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017.  Full Article

Shanghai Pharmaceuticals Holding To Place 153.2 Mln New H Shares At HK$20.43 Per H Share​
Friday, 19 Jan 2018 

Jan 19 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd 2607.HK::‍TO PLACE 153.2 MILLION NEW H SHARES AT HK$20.43 PER H SHARE​.‍NET PROCEEDS FROM PLACING EXPECTED TO BE HK$3,116.79 MILLION​.PROCEEDS TO FUND DEVELOPMENT OF PHARMACEUTICAL MANUFACTURING & DISTRIBUTION BUSINESSES & REPLENISH ITS WORKING CAPITAL​.  Full Article

Shanghai Pharmaceuticals Holding units receive GMP certificate
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line .Says the valid period is until Dec. 25, 2022.Says Shanghai-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for its products including flurbiprofen axetil .Says the valid period is until Dec. 26, 2022 .  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug .Says the valid period is until Dec. 25, 2022.  Full Article

Shanghai Pharmaceuticals Holding Announces ‍CSRC's Approval On Issuance Of New Shares
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::ANNOUNCES ‍CSRC'S APPROVAL ON ISSUANCE OF NEW 153.2 MILLION H SHARES AT VALUE OF RMB1 PER SHARE​.  Full Article

Shanghai Pharmaceuticals Holding To Transfer Entire Stake In Shanghai Huashi Asset Management
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::ANNOUNCES ‍TRANSFER OF 100% EQUITY INTEREST IN SHANGHAI HUASHI ASSET MANAGEMENT CO TO A CONTROLLING SHAREHOLDER​.DEAL FOR RMB218.1 MILLION​.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .* Certificate issued pill and Chinese medicine extraction workshop of the unit and the valid period is until Nov. 30, 2022.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Tuesday, 5 Dec 2017 

Dec 5(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> : :Says its Shanghai-based unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration.Says the valid period is until Nov. 27, 2022.  Full Article